IBDEI1QS ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29561,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,29562,0)
 ;;=D35.2^^115^1472^9
 ;;^UTILITY(U,$J,358.3,29562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29562,1,3,0)
 ;;=3^Prolactinoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,29562,1,4,0)
 ;;=4^D35.2
 ;;^UTILITY(U,$J,358.3,29562,2)
 ;;=^5002145
 ;;^UTILITY(U,$J,358.3,29563,0)
 ;;=Z13.1^^115^1472^10
 ;;^UTILITY(U,$J,358.3,29563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29563,1,3,0)
 ;;=3^Screen,Diabetes
 ;;^UTILITY(U,$J,358.3,29563,1,4,0)
 ;;=4^Z13.1
 ;;^UTILITY(U,$J,358.3,29563,2)
 ;;=^5062700
 ;;^UTILITY(U,$J,358.3,29564,0)
 ;;=Z13.220^^115^1472^11
 ;;^UTILITY(U,$J,358.3,29564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29564,1,3,0)
 ;;=3^Screen,Lipids
 ;;^UTILITY(U,$J,358.3,29564,1,4,0)
 ;;=4^Z13.220
 ;;^UTILITY(U,$J,358.3,29564,2)
 ;;=^5062702
 ;;^UTILITY(U,$J,358.3,29565,0)
 ;;=Z13.29^^115^1472^12
 ;;^UTILITY(U,$J,358.3,29565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29565,1,3,0)
 ;;=3^Screen,Thyroid
 ;;^UTILITY(U,$J,358.3,29565,1,4,0)
 ;;=4^Z13.29
 ;;^UTILITY(U,$J,358.3,29565,2)
 ;;=^5062704
 ;;^UTILITY(U,$J,358.3,29566,0)
 ;;=N70.01^^115^1473^12
 ;;^UTILITY(U,$J,358.3,29566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29566,1,3,0)
 ;;=3^Salpingitis,Acute
 ;;^UTILITY(U,$J,358.3,29566,1,4,0)
 ;;=4^N70.01
 ;;^UTILITY(U,$J,358.3,29566,2)
 ;;=^5015802
 ;;^UTILITY(U,$J,358.3,29567,0)
 ;;=A63.0^^115^1473^19
 ;;^UTILITY(U,$J,358.3,29567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29567,1,3,0)
 ;;=3^Verereal Warts
 ;;^UTILITY(U,$J,358.3,29567,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,29567,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,29568,0)
 ;;=B37.3^^115^1473^1
 ;;^UTILITY(U,$J,358.3,29568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29568,1,3,0)
 ;;=3^Candidiasis
 ;;^UTILITY(U,$J,358.3,29568,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,29568,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,29569,0)
 ;;=N72.^^115^1473^2
 ;;^UTILITY(U,$J,358.3,29569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29569,1,3,0)
 ;;=3^Cervicitis
 ;;^UTILITY(U,$J,358.3,29569,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,29569,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,29570,0)
 ;;=A74.89^^115^1473^3
 ;;^UTILITY(U,$J,358.3,29570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29570,1,3,0)
 ;;=3^Chlamydia (Culture +)
 ;;^UTILITY(U,$J,358.3,29570,1,4,0)
 ;;=4^A74.89
 ;;^UTILITY(U,$J,358.3,29570,2)
 ;;=^5000387
 ;;^UTILITY(U,$J,358.3,29571,0)
 ;;=Z11.8^^115^1473^13
 ;;^UTILITY(U,$J,358.3,29571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29571,1,3,0)
 ;;=3^Screen,Chlamydia
 ;;^UTILITY(U,$J,358.3,29571,1,4,0)
 ;;=4^Z11.8
 ;;^UTILITY(U,$J,358.3,29571,2)
 ;;=^5062677
 ;;^UTILITY(U,$J,358.3,29572,0)
 ;;=A56.02^^115^1473^4
 ;;^UTILITY(U,$J,358.3,29572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29572,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,29572,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,29572,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,29573,0)
 ;;=Z20.2^^115^1473^5
 ;;^UTILITY(U,$J,358.3,29573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29573,1,3,0)
 ;;=3^Contact with/Exposure to Infection,Sexual Mode of Transmission
 ;;^UTILITY(U,$J,358.3,29573,1,4,0)
 ;;=4^Z20.2
 ;;^UTILITY(U,$J,358.3,29573,2)
 ;;=^5062764
 ;;^UTILITY(U,$J,358.3,29574,0)
 ;;=N71.9^^115^1473^6
 ;;^UTILITY(U,$J,358.3,29574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29574,1,3,0)
 ;;=3^Endometritis
 ;;^UTILITY(U,$J,358.3,29574,1,4,0)
 ;;=4^N71.9
 ;;^UTILITY(U,$J,358.3,29574,2)
 ;;=^5015811
 ;;^UTILITY(U,$J,358.3,29575,0)
 ;;=A54.00^^115^1473^7
 ;;^UTILITY(U,$J,358.3,29575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29575,1,3,0)
 ;;=3^Gonorrhea (Culture +),Lower GU Tract
